英語 での The lifetime risk の使用例とその 日本語 への翻訳
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
-
Programming
The lifetime risk of colorectal cancer for most people is 5%.
In the unexposed Japanese population, the lifetime risk of leukemia is about 7 cases per 1000 people.
The lifetime risk of developing small intestine cancer was 4.2%.
Most cases of prostate cancer have a good prognosis,but some are aggressive; the lifetime risk of dying from prostate cancer is 2.8%.
The lifetime risk is roughly the same for both men and women.
Folks who are exposed invery high doses have triple the lifetime risk of heart disease and lung cancer and a 20-year difference in life expectancy.
The lifetime risk of being diagnosed with ovarian cancer is 1.31%.
About 4.5% of Americansare expected to develop the disease within their lifetime, and the lifetime risk of dying from CRC is 1.9.
The lifetime risk of prostate cancer is 14.3%; prostate cancer will be.
The estimated lifetime risk of a prostate cancer diagnosis is about 14.0%,[5] and the lifetime risk of dying from this disease is 2.6.
The lifetime risk for colon cancer in the general population is 5 percent.
Most cases of prostate cancer have a good prognosis even without treatment,but some cases are aggressive; the lifetime risk for dying of prostate cancer is 2.8%.
The lifetime risk for AA is nearly 2%, or two in every 100 people will get AA at some point in their lives.
Although invasive lobular breast cancer representsonly 10% to 15% of all breast cancers, the lifetime risk of lobular breast cancer in carriers of CDH1 pathogenic variants ranges from 30% to 50%.
(By contrast, the lifetime risk of breast cancer for the average American woman is about 12 percent.).
The lifetime risk of CRC and endometrial cancer in carriers of these pathogenic variants is summarized in Table 12.
Assuming a lifetime risk of breast cancer of 6%(the general-population risk seen in Poland;this is lower than what is seen in the United States), the lifetime risk of breast cancer for a woman with a CHEK2 mutation was estimated to be 20% if there was no family history of breast cancer, 28% if one second-degree relative had breast cancer, 34% if one first-degree relative had breast cancer, and 44% if both a first- and second-degree relative had breast cancer.
The lifetime risk of a fracture of the hip, spine or forearm is 40% in white women and 13% in white men.
A person with an ACE score of seven or more had triple the lifetime risk of lung cancer and three and a half times the risk of ischemic heart disease,the number one killer in the United States of America.
The lifetime risks of cardiovascular disease have not been reported across the age spectrum in black adults and white adults.
In this study, the lifetime risk in carriers was estimated to be 89% by age 85 years and 3.9% for noncarriers.
The lifetime risk of ovarian cancer is estimated to be 39-46% among women with a BRCA1 mutation and 12-20% among women with a BRCA2 mutation.
Added text to state that the lifetime risk of lung cancer was estimated in a Swiss population to be 15% in men who smoke and 12% in women who smoke, compared with 2% or less in nonsmokers(cited Bruder et al. as reference 16).
The lifetime risk of developing high blood pressure is estimated to be 90% and is predicted to affect 1.56 billion people worldwide by 2025(2).
In general, the lifetime risk of a second cancer is highest in people treated for cancer as children or adolescents(16).
The lifetime risk for liver cancer in the United States is about 1 percent; approximately eight adults per 100,000 will develop liver cancer in a given year.
The lifetime risk for developing ovarian cancer in patients harboring germline mutations in BRCA1 is substantially increased over that of the general population.
The lifetime risk of ovarian carcinoma in females with Lynch syndrome is estimated to be as high as 12%, and the reported RR of ovarian cancer has ranged from 3.6 to 13, based on families ascertained from high-risk clinics with known or suspected Lynch syndrome.
But because the lifetime risk of developing the disease is relatively low(estimated at 1.3 percent) and the increased risk associated with blood type relatively modest, screening tests for pancreatic cancer risk are unlikely to be based on blood type alone.